Structural variation in the glycogen synthase kinase 3β and brain‐derived neurotrophic factor genes in Japanese patients with bipolar disorders

• Main Authors: Yosuke Suga (Author), Keiichiro Yoshimoto (Author), Shusuke Numata (Author), Shinji Shimodera (Author), Shogo Takamura (Author), Naoto Kamimura (Author), Ken Sawada (Author), Hiromitsu Kazui (Author), Tetsuro Ohmori (Author), Shigeru Morinobu (Author)
• Format: Book
• Published: Wiley, 2020-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Lithium is the first‐line drug for the treatment of bipolar disorders (BDs); however, not all patients responded. Glycogen synthase kinase (GSK) 3β and brain‐derived neurotrophic factor (BDNF) play a role in the therapeutic action of lithium. Since structural variations were repo...